PROTEIN-KINASE C-DELTA-SPECIFIC PHOSPHORYLATION OF THE ELONGATION-FACTOR EEF-1-ALPHA AND AN EEF-1-ALPHA PEPTIDE AT THREONINE 431

被引:69
作者
KIELBASSA, K
MULLER, HJ
MEYER, HE
MARKS, F
GSCHWENDT, M
机构
[1] GERMAN CANC RES CTR, D-69120 HEIDELBERG, GERMANY
[2] RUHR UNIV BOCHUM, D-44780 BOCHUM, GERMANY
关键词
D O I
10.1074/jbc.270.11.6156
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two cytosolic proteins of murine epidermis or porcine spleen with molecular masses of 37 kDa (p37) and 50 kDa (p50) are differentially phosphorylated in vitro by the purified protein kinase C (PKC) isoenzymes alpha, beta, gamma (cPKC) and PKC delta. p37, identified as annexin I, is preferentially phosphorylated by cPKC, whereas p50, identified as elongation factor eEF-1 alpha, is phosphorylated with much greater efficacy by PKC delta than by cPKC. Using the recombinant PKC isoenzymes alpha, beta, gamma, delta, epsilon, eta, and zeta, we could show that purified eEF-1 alpha is indeed a specific substrate of PKC delta. It is not significantly phosphorylated by PKC epsilon, -eta and -zeta and only slightly by PKC alpha, -beta, and -gamma. PKC delta phosphorylates eEF-1 alpha at Thr-431 (based on the murine amino acid sequence). The peptide RFAVRDMRQTVAVGVIKAVDKK with a sequence corresponding to that of 422-443 from murine eEF-1 alpha and containing Thr-431 is an absolutely specific substrate for the delta-type of PKC. The single basic amino acid close to Thr-431 (Arg-429) is essential for recognition of the peptide as a substrate by PKC delta and for the selectivity of this recognition. Substitution of Arg-429 by alanine abolishes the ability of PKC delta to phosphorylate the peptide, and insertion of additional basic amino acids in the vicinity of Thr-431 causes a complete loss of selectivity.
引用
收藏
页码:6156 / 6162
页数:7
相关论文
共 64 条
[1]  
AKIMOTO K, 1994, J BIOL CHEM, V269, P12677
[2]   ISOLATION AND CHARACTERIZATION OF PKC-L, A NEW MEMBER OF THE PROTEIN-KINASE C-RELATED GENE FAMILY SPECIFICALLY EXPRESSED IN LUNG, SKIN, AND HEART [J].
BACHER, N ;
ZISMAN, Y ;
BERENT, E ;
LIVNEH, E .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) :126-133
[3]   THE POTENTIAL OF PROTEIN-KINASE-C AS A TARGET FOR ANTICANCER TREATMENT [J].
BASU, A .
PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) :257-280
[4]   FAILURE OF WILD-TYPE OR A MUTANT FORM OF PROTEIN KINASE-C-ALPHA TO TRANSFORM FIBROBLASTS [J].
BORNER, C ;
FILIPUZZI, I ;
WEINSTEIN, IB ;
IMBER, R .
NATURE, 1991, 353 (6339) :78-80
[5]  
BURNS DJ, 1990, J BIOL CHEM, V265, P12044
[6]  
CACACE AM, 1993, ONCOGENE, V8, P2095
[7]   CHANGES IN ACTIVITY AND AMOUNT OF ACTIVE ELONGATION-FACTOR 1-ALPHA IN AGING AND IMMORTAL HUMAN FIBROBLAST-CULTURES [J].
CAVALLIUS, J ;
RATTAN, SIS ;
CLARK, BFC .
EXPERIMENTAL GERONTOLOGY, 1986, 21 (03) :149-157
[8]   MULTIPLE, DISTINCT FORMS OF BOVINE AND HUMAN PROTEIN-KINASE-C SUGGEST DIVERSITY IN CELLULAR SIGNALING PATHWAYS [J].
COUSSENS, L ;
PARKER, PJ ;
RHEE, L ;
YANGFENG, TL ;
CHEN, E ;
WATERFIELD, MD ;
FRANCKE, U ;
ULLRICH, A .
SCIENCE, 1986, 233 (4766) :859-866
[9]   PROTEIN-KINASE-C - A QUESTION OF SPECIFICITY [J].
DEKKER, LV ;
PARKER, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (02) :73-77
[10]   BIOCHEMICAL-PROPERTIES OF RAT PROTEIN-KINASE C-ETA EXPRESSED IN COS CELLS [J].
DEKKER, LV ;
PARKER, PJ ;
MCINTYRE, P .
FEBS LETTERS, 1992, 312 (2-3) :195-199